Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Pioneering genetic research to advance diagnosis and therapies for inherited retinal diseases.

  • Edit
DateInvestorsAmountRound

N/A

Spinout
Total Funding000k
Notes (0)
More about Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Made with AI
Edit

IOB is an international research institute focused on advancing the understanding and treatment of inherited retinal diseases. By conducting extensive genetic studies, particularly in regions like Pakistan, IOB aims to uncover unique mutational patterns that can inform diagnosis and future therapies. The institute operates within the biomedical research sector, leveraging substantial financial support from the Canton of Basel Stadt. IOB fosters a collaborative environment that values diversity and interdisciplinary exchange, uniting researchers and clinicians in the mission to restore vision. The business model is centered around research and development, with funding from public and private partnerships. Key clients include academic institutions, healthcare providers, and governmental bodies interested in genetic research and therapeutic advancements.

Keywords: genetic research, retinal diseases, diagnosis, therapies, interdisciplinary, collaboration, biomedical, public-private, vision restoration, Basel.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads